Details

Autor(en) / Beteiligte

• D’Amico, Gennaro
• Maruzzelli, Luigi
• Airoldi, Aldo
• Petridis, Ioannis
• Tosetti, Giulia
• Rampoldi, Antonio
• D’Amico, Mario
• Miraglia, Roberto
• De Nicola, Stella
• La Mura, Vincenzo
• Solcia, Marco
• Volpes, Riccardo
• Perricone, Giovanni
• Sgrazzutti, Cristiano
• Vanzulli, Angelo
• Primignani, Massimo
• Luca, Angelo
• Malizia, Giuseppe
• Federico, Alessandro
• Dallio, Marcello
• Andriulli, Angelo
• Iacobellis, Angelo
• Addario, Luigi
• Garcovich, Matteo
• Gasbarrini, Antonio
• Chessa, Luchino
• Salerno, Francesco
• Gobbo, Giulia
• Merli, Manuela
• Ridola, Lorenzo
• Baroni, Gianluca Svegliati
• Tarantino, Giuseppe
• Caporaso, Nicola
• Morisco, Filomena
• Pozzoni, Pietro
• Colli, Agostino
• Belli, Luca Saverio

Titel

Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology

Ist Teil von

• Journal of hepatology, 2021-12, Vol.75 (6), p.1355-1366

Ort / Verlag

Netherlands: Elsevier B.V

Erscheinungsjahr

2021

Quelle

MEDLINE

Beschreibungen/Notizen

• Although the discriminative ability of the model for end-stage liver disease (MELD) score is generally considered acceptable, its calibration is still unclear. In a validation study, we assessed the discriminative performance and calibration of 3 versions of the model: original MELD-TIPS, used to predict survival after transjugular intrahepatic portosystemic shunt (TIPS); classic MELD-Mayo; and MELD-UNOS, used by the United Network for Organ Sharing (UNOS). We also explored recalibrating and updating the model. In total, 776 patients who underwent elective TIPS (TIPS cohort) and 445 unselected patients (non-TIPS cohort) were included. Three, 6 and 12-month mortality predictions were calculated by the 3 MELD versions: discrimination was assessed by c-statistics and calibration by comparing deciles of predicted and observed risks. Cox and Fine and Grey models were used for recalibration and prognostic analyses. In the TIPS/non-TIPS cohorts, the etiology of liver disease was viral in 402/188, alcoholic in 185/130, and non-alcoholic steatohepatitis in 65/33; mean follow-up±SD was 25±9/19±21 months; and the number of deaths at 3-6-12 months was 57-102-142/31-47-99, respectively. C-statistics ranged from 0.66 to 0.72 in TIPS and 0.66 to 0.76 in non-TIPS cohorts across prediction times and scores. A post hoc analysis revealed worse c-statistics in non-viral cirrhosis with more pronounced and significant worsening in the non-TIPS cohort. Calibration was acceptable with MELD-TIPS but largely unsatisfactory with MELD-Mayo and -UNOS whose performance improved much after recalibration. A prognostic analysis showed that age, albumin, and TIPS indication might be used to update the MELD. In this validation study, the performance of the MELD score was largely unsatisfactory, particularly in non-viral cirrhosis. MELD recalibration and candidate variables for an update to the MELD score are proposed. While the discriminative performance of the model for end-stage liver disease (MELD) score is credited to be fair to good, its calibration, the correspondence of observed to predicted mortality, is still unsettled. We found that application of 3 different versions of the MELD in 2 independent cirrhosis cohorts yielded largely imprecise mortality predictions particularly in non-viral cirrhosis. Thus, we propose a recalibration and suggest candidate variables for an update to the model. [Display omitted] •Discrimination of MELD is widely reported as fair to good, although its calibration is still unclear.•In 2 cirrhosis cohorts we found barely acceptable c-statistics, which were significantly worse in patients with non-viral etiology.•Calibration was largely unsatisfactory with the Mayo and UNOS MELD versions.•Validated recalibrations of MELD-Mayo and UNOS versions are presented which allow reliable predictions for clinical practice.•Age, albumin and ascites as the indication for TIPS are candidate variables for an update to the MELD-TIPS score.